.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Frank Gaunitz

Leipzig

Uniklinikum Leipzig

Further involvements

Mo, 10/06/2024
08:05 – 08:10 3 Min. 2 Min.
ePoster
P061
Untersuchung der Mechanismen, die für die antineoplastische Wirkung von Metformin bei malignen Gliomen verantwortlich sind
Investigation of the mechanisms responsible for the antineoplastic effect of metformin in malignant gliomas
Tumor
Mo, 10/06/2024
08:25 – 08:30 3 Min. 2 Min.
ePoster
P050
Der Proteasom-Inhibitor Marizomib zeigt antiproliferative Wirkung in allen drei Meningeom-Graden
The proteasome inhibitor marizomib shows antiproliferative effects in all three grades of meningioma
Tumor
Tu, 11/06/2024
15:20 – 15:30 7 Min. 3 Min.
Abstractvortrag | Abstract talk
V198
Die Hemmung der Protein Tyrosin Phosphatase PTP1B mittels dem small molecule Claramine inhibiert die EGF-vermittelte Wachstumssteigerung in Glioblastozellen durch Hemmung des MAPK Signalwegs
Inhibition of the protein tyrosine phosphatase PTP1B by the small molecule inhibitor claramine inhibits growth stimulation by EGF in glioblastoma cells via inhibition of the MAPK pathway
Tumor